Evidence map›Paper›PMID 23197533›Full record

ArticleScience (New York, N.Y.)2012

An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution.

Christopher Williams, Hans-Jürgen Hoppe, Dellel Rezgui, Madeleine Strickland, Briony E Forbes, Frank Grutzner, Susana Frago, Rosamund Z Ellis, Pakorn Wattana-Amorn, Stuart N Prince and 6 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  18. Article
  19. Rapid molecular evolution across amniotes of the IIS/TOR network.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Christopher WilliamsDepartment of Organic and Biological Chemistry, School of Chemistry, University of Bristol, Bristol BS8 1TS, UK.
Hans-Jürgen Hoppe
Dellel Rezgui
Madeleine Strickland
Briony E Forbes
Frank Grutzner
Susana Frago
Rosamund Z Ellis
Pakorn Wattana-Amorn
Stuart N Prince
Oliver J Zaccheo
Catherine M Nolan
Andrew J Mungall
E Yvonne Jones
Matthew P Crump
A Bassim Hassan
University of Bristol · GBUniversity of Adelaide · AUCanada's Michael Smith Genome Sciences Centre · CAUniversity College Dublin · IEUniversity of Oxford · GB

Funding

Cancer Research UK 9891Cancer Research UK A13295Cancer Research UK A9891Cancer Research UK C375Cancer Research UK C429Wellcome Trust 082352Wellcome Trust 090532
6 · The paper itself

Abstract

Placental development and genomic imprinting coevolved with parental conflict over resource distribution to mammalian offspring. The imprinted genes IGF2 and IGF2R code for the growth promoter insulin-like growth factor 2 (IGF2) and its inhibitor, mannose 6-phosphate (M6P)/IGF2 receptor (IGF2R), respectively. M6P/IGF2R of birds and fish do not recognize IGF2. In monotremes, which lack imprinting, IGF2 specifically bound M6P/IGF2R via a hydrophobic CD loop. We show that the DNA coding the CD loop in monotremes functions as an exon splice enhancer (ESE) and that structural evolution of binding site loops (AB, HI, FG) improved therian IGF2 affinity. We propose that ESE evolution led to the fortuitous acquisition of IGF2 binding by M6P/IGF2R that drew IGF2R into parental conflict; subsequent imprinting may then have accelerated affinity maturation.

Indexed as

Alternative SplicingEvolution, MolecularExonsAmino Acid SequenceAnimalsBinding SitesConserved SequenceEnhancer Elements, GeneticGenomic ImprintingHumansInsulin-Like Growth Factor IIMolecular Sequence DataPhylogenyProtein Structure, TertiaryReceptor, IGF Type 2Species SpecificityInsulin-Like Growth Factor IIReceptor, IGF Type 2

Identifiers

PMID23197533
PMCPMC4658703
OpenAlexW2046155010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.